PMD68 - A COST-CONSEQUENCE ANALYSIS OF ANACONDA VERSUS PROPOFOL AND MIDAZOLAM IN THE LONG-TERM SEDATION OF CRITICALLY-ILL SURGICAL PATIENTS FROM THE UK NHS PERSPECTIVE
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.1517
https://www.valueinhealthjournal.com/article/S1098-3015(18)34819-8/fulltext
Title :
PMD68 - A COST-CONSEQUENCE ANALYSIS OF ANACONDA VERSUS PROPOFOL AND MIDAZOLAM IN THE LONG-TERM SEDATION OF CRITICALLY-ILL SURGICAL PATIENTS FROM THE UK NHS PERSPECTIVE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)34819-8&doi=10.1016/j.jval.2018.09.1517
First page :
Section Title :
Open access? :
No
Section Order :
893